Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure
Open Access
- 11 May 2005
- journal article
- Published by American Physiological Society in Physiological Genomics
- Vol. 21 (3) , 314-323
- https://doi.org/10.1152/physiolgenomics.00185.2004
Abstract
Myocardial right ventricular (RV) hypertrophy due to pulmonary hypertension is aimed at normalizing ventricular wall stress. Depending on the degree of pressure overload, RV hypertrophy may progress to a state of impaired contractile function and heart failure, but this cannot be discerned during the early stages of ventricular remodeling. We tested whether critical differences in gene expression profiles exist between ventricles before the ultimate development of either a compensated or decompensated hypertrophic phenotype. Both phenotypes were selectively induced in Wistar rats by a single subcutaneous injection of either a low or a high dose of the pyrrolizidine alkaloid monocrotaline (MCT). Spotted oligonucleotide microarrays were used to investigate pressure-dependent cardiac gene expression profiles at 2 wk after the MCT injections, between control rats and rats that would ultimately develop either compensated or decompensated hypertrophy. Clustering of significantly regulated genes revealed specific expression profiles for each group, although the degree of hypertrophy was still similar in both. The ventricles destined to progress to failure showed activation of pro-apoptotic pathways, particularly related to mitochondria, whereas the group developing compensated hypertrophy showed blocked pro-death effector signaling via p38-MAPK, through upregulation of MAPK phosphatase-1. In summary, we show that, already at an early time point, pivotal differences in gene expression exist between ventricles that will ultimately develop either a compensated or a decompensated phenotype, depending on the degree of pressure overload. These data reveal genes that may provide markers for the early prediction of clinical outcome as well as potential targets for early intervention.Keywords
This publication has 47 references indexed in Scilit:
- Control of mitochondrial β-oxidation fluxProgress in Lipid Research, 2002
- Stage-dependent activation of cell cycle and apoptosis mechanisms in the right ventricle by pressure overloadBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2002
- Defective Intracellular Calcium Handling in Monocrotaline-Induced Right Ventricular Hypertrophy: Protective Effect of Long-Term Endothelin-A Receptor Blockade with 2-Benzo[1,3]dioxol-5-yl-3-benzyl-4-(4-methoxy-phenyl-)- 4-oxobut-2-enoate-sodium (PD 155080)The Journal of Pharmacology and Experimental Therapeutics, 2002
- Mitochondrial intermembrane junctional complexes and their involvement in cell deathBiochimie, 2002
- Gene Expression Omnibus: NCBI gene expression and hybridization array data repositoryNucleic Acids Research, 2002
- The Dual-Specificity Phosphatase MKP-1 Limits the Cardiac Hypertrophic Response In Vitro and In VivoCirculation Research, 2001
- Increased Cardiomyocyte Apoptosis and Changes in Proapoptotic and Antiapoptotic Genes bax and bcl -2 During Left Ventricular Adaptations to Chronic Pressure Overload in the RatCirculation, 1999
- Rat models of hypertension, cardiac hypertrophy and failurePublished by Oxford University Press (OUP) ,1998
- Skeletal Muscle Metabolism in Experimental Heart FailureJournal of Molecular and Cellular Cardiology, 1996
- Noradrenaline, atrial natriuretic peptide, bombesin and neurotensin in myocardium and blood of rats in congestive cardiac failureCardiovascular Research, 1989